Biogen Inc (HAM:IDP)
€ 180.14 +4.62 (+2.63%) Market Cap: 26.26 Bil Enterprise Value: 28.27 Bil PE Ratio: 21.67 PB Ratio: 1.60 GF Score: 74/100

Biogen Inc at Leerink Global Healthcare Conference Transcript

Mar 10, 2026 / 05:00PM GMT
Release Date Price: €162.1 (+1.53%)
Marc Goodman
Leerink Partners LLC - Analyst

All right, let's start back.

Thank you everybody for, joining us for our next session. We, I'm Mark Goodman, one of the biopharma analysts at Lang Partners, and we have BioGen next and very interesting head of West Coast Hub, Uktal Patel, I'll let him give a little bit of, background of how he got to the company and how this West Coast hub has been, started, but, very interesting for the company to do that, through this acquisition that you'll hear about. And obviously a very interesting asset that we're going to go through all the different indications and stuff, but I do think maybe just for sixty seconds just give your background and how the West Coast hub is like, what does it look like and how it's evolved, what the goals are.

Uptal Patel
Biogen Inc - Head, West Coast Hub

Sure, well, my name's Zupal Patel, as Mark mentioned, thanks for having us and, be making some forward-looking statements. So just the usual disclaimers to look at the risks in our SEC filings, because those.

Results might

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot